Oracle (NYSE:ORCL) Shares Down 1.7% – What’s Next?

Oracle Corporation (NYSE:ORCL)’s stock price traded down 1.7% during trading on Wednesday . The stock traded as low as $154.00 and last traded at $157.1840. 24,311,166 shares changed hands during trading, a decline of 14% from the average session volume of 28,215,982 shares. The stock had previously closed at $159.89.

Trending Headlines about Oracle

Here are the key news stories impacting Oracle this week:

• Positive Sentiment: CMS selects Oracle Cloud Infrastructure to support its modernization initiative — a material federal win that validates OCI for mission‑critical workloads and likely supports backlog and OCI demand. Oracle Cloud Infrastructure to Support Centers for Medicare and Medicaid’s Modernization Initiative
• Positive Sentiment: Oracle rolled out AI agents for Fusion Apps and highlighted strong cloud revenue growth (cloud +34%, RPO surge), reinforcing the company’s AI monetization narrative and recurring SaaS revenue momentum. Oracle Unveils AI Agents for Fusion Apps: Will it Boost Prospects?
• Positive Sentiment: DA Davidson and other firms upgraded ORCL recently, sparking a sharp short‑covering rally earlier in the week and providing a near‑term technical lift. DA Davidson Upgrades Oracle (NYSE:ORCL) to “Buy”
• Positive Sentiment: Renewed optimism around OpenAI exposure (and other AI partner activity) has supported investor sentiment that Oracle can capture meaningful AI cloud demand. Oracle (ORCL) gets fresh boost from optimism around OpenAI exposure
• Neutral Sentiment: Oracle Health customer wins (Hillsboro Health) and other product launches show steady commercial traction in healthcare and supply chain—positive for execution but smaller in near‑term revenue impact. Hillsboro Health Chooses AI-Powered Oracle Health Solutions to Help Advance Patient Care, Optimize Operations
• Neutral Sentiment: Short interest rose in January (shares sold short increased ~19.5% month‑over‑month). That amplifies volatility risk—could fuel squeezes or further downside depending on flows.
• Negative Sentiment: Multiple securities‑fraud class actions and shareholder alerts were filed this week (several law firms notifying investors), creating legal overhang and potential settlement risk that is weighing on the stock. Oracle Corporation Sued for Securities Law Violations – Contact The Gross Law Firm Before April 6, 2026 to Discuss Your Rights – ORCL Oracle Corporation (ORCL) Investors: Kessler Topaz Meltzer & Check, LLP Announces Lawsuit
• Negative Sentiment: Some sell‑side and media skepticism: Melius downgraded or lowered ratings citing AI monetization uncertainty, and high‑profile commentators flagged balance‑sheet concerns—both contributed to intraday selling pressure. Melius Downgrades Oracle (ORCL) to Hold Jim Cramer on Oracle (ORCL): “I Don’t Like What They’re Doing to Their Balance Sheet”

Analysts Set New Price Targets

A number of equities analysts recently commented on ORCL shares. Barclays reiterated an “overweight” rating on shares of Oracle in a report on Monday, February 2nd. JPMorgan Chase & Co. cut their price objective on shares of Oracle from $270.00 to $230.00 and set a “neutral” rating for the company in a report on Thursday, December 11th. Robert W. Baird reduced their target price on Oracle from $365.00 to $315.00 and set an “outperform” rating on the stock in a report on Tuesday, November 18th. Jefferies Financial Group reissued a “buy” rating and issued a $400.00 price objective on shares of Oracle in a research note on Monday, January 5th. Finally, Stephens boosted their target price on Oracle from $208.00 to $331.00 and gave the stock an “equal weight” rating in a research note on Friday, October 17th. Three analysts have rated the stock with a Strong Buy rating, twenty-six have given a Buy rating, eleven have given a Hold rating and one has given a Sell rating to the stock. According to MarketBeat.com, the company has a consensus rating of “Moderate Buy” and an average target price of $292.43.

Oracle Trading Down 1.7%

The company has a market capitalization of $451.61 billion, a P/E ratio of 29.55, a PEG ratio of 1.37 and a beta of 1.64. The business has a fifty day moving average of $187.05 and a 200-day moving average of $232.85. The company has a debt-to-equity ratio of 3.28, a quick ratio of 0.91 and a current ratio of 0.91.

Oracle (NYSE:ORCL) last announced its quarterly earnings results on Wednesday, December 10th. The enterprise software provider reported $2.26 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.64 by $0.62. Oracle had a return on equity of 70.60% and a net margin of 25.28%.The business had revenue of $16.06 billion during the quarter, compared to the consensus estimate of $16.19 billion. During the same quarter in the prior year, the company posted $1.47 earnings per share. Oracle’s revenue was up 14.2% compared to the same quarter last year. Analysts anticipate that Oracle Corporation will post 5 earnings per share for the current fiscal year.

Oracle Announces Dividend

The company also recently disclosed a quarterly dividend, which was paid on Friday, January 23rd. Investors of record on Friday, January 9th were paid a $0.50 dividend. The ex-dividend date was Friday, January 9th. This represents a $2.00 annualized dividend and a yield of 1.3%. Oracle’s dividend payout ratio is presently 37.59%.

Insider Transactions at Oracle

In other Oracle news, CEO Clayton M. Magouyrk sold 10,000 shares of the firm’s stock in a transaction on Friday, December 19th. The stock was sold at an average price of $192.52, for a total value of $1,925,200.00. Following the completion of the sale, the chief executive officer directly owned 144,030 shares of the company’s stock, valued at $27,728,655.60. This trade represents a 6.49% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available through this link. Also, Director Naomi O. Seligman sold 2,223 shares of the company’s stock in a transaction on Tuesday, December 23rd. The shares were sold at an average price of $196.61, for a total value of $437,064.03. Following the transaction, the director directly owned 25,596 shares in the company, valued at $5,032,429.56. This represents a 7.99% decrease in their position. The disclosure for this sale is available in the SEC filing. Insiders sold a total of 62,223 shares of company stock valued at $12,136,764 in the last three months. 40.90% of the stock is currently owned by company insiders.

Institutional Inflows and Outflows

Several institutional investors have recently modified their holdings of the stock. FSA Wealth Management LLC purchased a new stake in Oracle during the 3rd quarter valued at about $28,000. Darwin Wealth Management LLC raised its holdings in Oracle by 130.0% in the third quarter. Darwin Wealth Management LLC now owns 115 shares of the enterprise software provider’s stock worth $32,000 after purchasing an additional 65 shares in the last quarter. Mpwm Advisory Solutions LLC lifted its position in Oracle by 76.9% during the 3rd quarter. Mpwm Advisory Solutions LLC now owns 115 shares of the enterprise software provider’s stock valued at $32,000 after acquiring an additional 50 shares during the period. Turning Point Benefit Group Inc. bought a new stake in shares of Oracle in the 3rd quarter worth approximately $35,000. Finally, HFM Investment Advisors LLC grew its stake in shares of Oracle by 290.9% in the fourth quarter. HFM Investment Advisors LLC now owns 129 shares of the enterprise software provider’s stock worth $25,000 after acquiring an additional 96 shares during the last quarter. 42.44% of the stock is currently owned by institutional investors.

About Oracle

Oracle Corporation is a multinational technology company that develops and sells database software, cloud engineered systems, enterprise software applications and related services. The company is widely known for its flagship Oracle Database and a portfolio of enterprise-grade software products that support data management, application development, analytics and middleware. Over recent years Oracle has expanded its focus to include cloud infrastructure and cloud applications, positioning itself as a provider of both platform and software-as-a-service solutions for large organizations.

Oracle’s product and service offerings include Oracle Database and the Autonomous Database, Oracle Cloud Infrastructure (OCI), enterprise resource planning (ERP), human capital management (HCM) and supply chain management (SCM) cloud applications (often grouped under Oracle Fusion Cloud Applications), middleware such as WebLogic, and developer technologies including Java and MySQL.